Aripiprazole – therapeutic efficacy and safety in everyday practice
Aripiprazole differs from other antipsychotics in its unique mechanism of action: as a partial D2 and 5-HT1A agonist and a 5-HT2A antagonist, it acts as a dopamine system stabiliser. The drug allows controlling positive, negative and cognitive symptoms of schizophrenia. The indications in the summar...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Communications Sp. z o.o.
2019-12-01
|
Series: | Psychiatria i Psychologia Kliniczna |
Subjects: | |
Online Access: | http://www.psychiatria.com.pl/index.php/wydawnictwa/2019-vol-19-no-4/aripiprazole-therapeutic-efficacy-and-safety-in-everyday-practice?aid=910 |